Renal Cancer - Results from #6800

Controversies of partial nephrectomy for renal cell carcinoma: Survey in the German-speaking countries - Abstract July 21, 2014

The therapeutic potential of ablative radiotherapy for metastatic renal cell cancer: A tumour deemed radiation resistant - Abstract July 18, 2014

Clear cell renal cell carcinoma (ccRCC) with hemangioblastoma-like features: A previously unreported pattern of ccRCC with possible clinical significance - Abstract July 18, 2014

Robotic partial nephrectomy for cystic renal masses: A comparative analysis of a matched-paired cohort - Abstract July 18, 2014

Efficacy of targeted therapy for metastatic renal cell carcinoma in the elderly patient population - Abstract July 18, 2014

Prognostic significance of cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma treated with first-line sunitinib: A European multiinstitutional study - Abstract July 18, 2014

The role of inflammation in kidney cancer - Abstract July 18, 2014

The ventricular system and choroid plexus as a primary site for renal cell carcinoma metastasis - Abstract July 16, 2014

Ampullary tumor caused by metastatic renal cell carcinoma and literature review - Abstract July 16, 2014

Discontinuation of the tyrosine kinase inhibitor sunitinib in patients with metastatic renal cell carcinoma: A case series - Abstract July 16, 2014

Obesity and renal cancer: Role of adipokines in the tumor-immune system conflict - Abstract July 15, 2014

Salivary neoplasms presenting with radiologic venous invasion: An imaging pearl to diagnosing metastatic renal cell carcinoma - Abstract July 15, 2014

Sunitinib re-challenge in advanced renal-cell carcinoma - Abstract July 15, 2014

Hand-assisted laparoscopic radical nephrectomy in pregnancy - Abstract July 14, 2014

Extracranial oligometastatic renal cell carcinoma: Current management and future directions - Abstract July 14, 2014

Unusual radiological behaviour after cryoablation of renal cell carcinoma - Abstract July 14, 2014

Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example - Abstract July 11, 2014

Sequential targeted therapy after pazopanib therapy in patients with metastatic renal cell cancer: Efficacy and toxicity - Abstract July 11, 2014

Assessment of efficacy, safety and quality of life of 110 patients treated with sunitinib as first-line therapy for metastatic renal cell carcinoma: Experience in real-world clinical practice in Japan - Abstract July 11, 2014

ACR appropriateness criteria post-treatment follow-up of renal cell carcinoma - Abstract July 11, 2014

Page 341 of 456